Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Autophagy
    (1)
  • Beta Amyloid
    (1)
  • LDLR
    (1)
  • Wnt/beta-catenin
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Nervous System
    (1)
Filter
Search Result
Results for "

neuropathology

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Dye Reagents
    1
    TargetMol | All_Dye_Reagents
CA77.1
T90622412270-22-3
CA77.1(CA) is a novel chaperon-mediated autophagy (CMA) activator for the treatment of Alzheimer's disease (AD).
  • $52
In Stock
Size
QTY
TargetMol | Citations Cited
SJ-300
T2146521210357-06-4
SJ-300 is a selective, orally active DKK3-LRP1 inhibitor capable of crossing the blood-brain barrier. It binds to mLRPIV with a Kd of 7.9 μM and inhibits the DKK3-mLRPIV complex with an IC50 of 3.2 μM, without affecting the interaction between Aβ and LRP1. In Alzheimer's disease models, SJ-300 restores Aβ clearance functionality, improves cognitive function, and reduces neuropathology by approximately 73.3% (Aβ plaque reduction). SJ-300 is suitable for research related to Alzheimer's disease.
  • Inquiry Price
10-14 weeks
Size
QTY